Dr. Nabil Ismaili

Medical Oncologist
Medical Oncology
Mohammed VI University Hospital, Marrakech, Morocco
Morocco

Scientist Oncology
Biography

After 5 years of medical school at Mohammed V University, Faculty of Medicine and Pharmacy and 2 years of medical practice at the University Hospital in Rabat - Morocco, he joined the department of medical oncology at the National Institute of Oncology in Rabat for a period of 4 years and the department of medical oncology at Lιon-bιrard Cancer Center in France for a period of 1 years and he get the degree of Medical Oncologist. The main research areas in which he participated concerned different types and aspects of cancer diseases: Breast and gynecologic cancers, urological cancers, gastro-intestinal cancers and nasopharyngeal cancers. His team has contributed significantly to these fields and has published over than 70 peer-reviewed publications. He is an executive member in various associations in Cancer Research (MEACR: Meddle East Association of Cancer Research; ASCAS: Association Scientifique des Cancιrologues du Sud; AMFROM: The Moroccan Association of Training and Research in Medical Oncology). In addition, I have several certificates in different fields of oncology (short training in Morocco and abroad). He worked at regional cancer center of Agadir from July 2010 to July 2012. Currently He work as a Medical Oncologist at the Cancer Center of Marrakech in Morocco. Specialisations: Breast cancer and Urologic cancers. He is an editor of Books:    Management of gastric cancer: INTECH http://www.intechopen.com/books/management-of-gastric-cancer Handbook of urothelial cancers (in process): Nova Publishers Editorial Board member of several journals:   Journal of clinical urology and urologic thechnology; http://jcuut.uscip.us/. Journal of Nasopharyngeal Carcinoma, http://journalofnasopharyngealcarcinoma.org/. Case report in urology, http://www.hindawi.com/crim/urology/. The Open Access Journal of Science and Thechnology. Guest Editor: Curent Angiogenesis: Topic: Antiangiogenic agents in solid malignancies.   

Research Intrest

Medical Oncology